HUYA Bioscience International LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:HUYA Bioscience International LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C2797
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
HUYA Bioscience International LLC (HUYA) is a biopharmaceutical company that develops early and late-stage drug candidates. The company’s pipeline products include HBI-8000, HBI-3000, and HBI-3802. Its HBI-8000 is a novel oral inhibitor of histone deacetylases; HBI-3000 is a channel blocker for the treatment of arrhythmia and HBI-3802 is a small molecule with preclinical activity to improve heart function. HUYA also identifies and licenses pre-clinical and clinical stage compounds. The company develops drugs in the areas of oncology and cardiovascular. It has operations in the US, Ireland, China, Japan and South Korea. HUYA is headquartered in Shanghai, China.

HUYA Bioscience International LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
HUYA Bioscience International LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
HUYA Bioscience International LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
HUYA Bioscience International LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
HUYA Bioscience International LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
HUYA Bioscience International LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
HUYA Bioscience International LLC, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
HUYA Bioscience International Enters into Agreement with CAS Innovation 10
Huya Bioscience to form Joint Venture with Tianjin Institute of Pharma 11
HUYA Bioscience Enters Into Co-Development Agreement With TJRCBMS 12
Licensing Agreements 13
HUYA Bioscience Enters into Licensing Agreement with Fudan University 13
HUYA Bioscience International Enters into Licensing Agreement with Eisai 14
HUYA Bioscience International LLC – Key Competitors 15
HUYA Bioscience International LLC – Key Employees 16
HUYA Bioscience International LLC – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
HUYA Bioscience International LLC, Pharmaceuticals & Healthcare, Key Facts 2
HUYA Bioscience International LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
HUYA Bioscience International LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
HUYA Bioscience International LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
HUYA Bioscience International LLC, Deals By Therapy Area, 2012 to YTD 2018 8
HUYA Bioscience International LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
HUYA Bioscience International Enters into Agreement with CAS Innovation 10
Huya Bioscience to form Joint Venture with Tianjin Institute of Pharma 11
HUYA Bioscience Enters Into Co-Development Agreement With TJRCBMS 12
HUYA Bioscience Enters into Licensing Agreement with Fudan University 13
HUYA Bioscience International Enters into Licensing Agreement with Eisai 14
HUYA Bioscience International LLC, Key Competitors 15
HUYA Bioscience International LLC, Key Employees 16
HUYA Bioscience International LLC, Other Locations 17

List of Figures
HUYA Bioscience International LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
HUYA Bioscience International LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
HUYA Bioscience International LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
HUYA Bioscience International LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
HUYA Bioscience International LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
HUYA Bioscience International LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
HUYA Bioscience International LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
HUYA Bioscience International LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[HUYA Bioscience International LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ramsay Health Care Ltd (RHC):企業の財務・戦略的SWOT分析
    Ramsay Health Care Ltd (RHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Varian Medical Systems Inc (VAR):企業の財務・戦略的SWOT分析
    Varian Medical Systems Inc (VAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • National Taiwan University Hospital-製薬・医療分野:企業M&A・提携分析
    Summary National Taiwan University Hospital (NTUH) is a healthcare service provider that offers biomedical, clinical research and patient care services. The hospital’s research activities include community-based intervention programs, multicenter controlled clinical trials, program projects, researc …
  • Qualicaps Inc:企業の戦略的SWOT分析
    Qualicaps Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • NuVasive Inc (NUVA)-医療機器分野:企業M&A・提携分析
    Summary NuVasive Inc (NuVasive) is a medical device company that provides minimally invasive, procedurally-integrated spine solutions. The company principally provides Maximum Access Surgery (MAS), a minimally-disruptive surgical platform. MAS platform enables surgeons to perform a range of minimall …
  • Yokogawa Electric Corp (6841):企業の財務・戦略的SWOT分析
    Yokogawa Electric Corp (6841) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Alacer Gold Corp:企業の戦略・SWOT・財務情報
    Alacer Gold Corp - Strategy, SWOT and Corporate Finance Report Summary Alacer Gold Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Ossur hf (OSSR):企業の財務・戦略的SWOT分析
    Ossur hf (OSSR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Abramson Cancer Center:製薬・医療:M&Aディール及び事業提携情報
    Summary Abramson Cancer Center (Abramson) formerly Penn Medicine's Cancer Center, a subsidiary of University of Pennsylvania is a healthcare service center that provides clinical trials for the prevention, diagnosis and treatment of cancer. The center provides supportive care services, which include …
  • Brinker International, Inc.:企業の戦略・SWOT・財務分析
    Brinker International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Brinker International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Flex Ltd (FLEX):医療機器:M&Aディール及び事業提携情報
    Summary Flex Ltd (Flex) provides design, engineering, manufacturing, and supply chain services to electronics original equipment manufacturers. The company, through its Sketch-to-Scale concept, provides concept design, prototype creation, intellectual property protection, new product introduction, a …
  • Belize Electricity Ltd:企業の戦略的SWOT分析
    Belize Electricity Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • ConvaTec Group Plc (CTEC):医療機器:M&Aディール及び事業提携情報
    Summary ConvaTec Group Plc (ConvaTec) is a medical products and technologies company that specializes in advanced wound care, ostomy care, continence and critical care, and infusion devices. Its major products include wound dressings, skin care products, disposable infusion sets, urological catheter …
  • OncBioMune Pharmaceuticals Inc (OBMP):企業の財務・戦略的SWOT分析
    Summary OncBioMune Pharmaceuticals Inc (OncBioMune), formerly Quint Media Inc is a biopharmaceutical company that develops novel cancer immunotherapy products. The company’s products comprise biosimilars and vaccines developed for cancer types such as renal, breast, prostrate, and ovarian cancer. It …
  • Essel Propack Limited:戦略・SWOT・企業財務分析
    Essel Propack Limited - Strategy, SWOT and Corporate Finance Report Summary Essel Propack Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Electricity Generating Authority of Thailand:企業の戦略的SWOT分析
    Electricity Generating Authority of Thailand - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Evergreen Packaging Llc:企業の戦略・SWOT・財務分析
    Evergreen Packaging Llc - Strategy, SWOT and Corporate Finance Report Summary Evergreen Packaging Llc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Batu Biologics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Batu Biologics Inc (Batu Biologics) is an immuno-oncology company. The company offers development and commercialization of novel therapies that target the Achilles Heel of cancer: the tumor blood vessels. Its lead product ValloVax is a cellular anti-angiogenic cancer vaccine that is develope …
  • Sutro Biopharma Inc-製薬・医療分野:企業M&A・提携分析
    Summary Sutro Biopharma Inc (Sutro), formerly Fundamental Applied Biology Inc, discovers and develops antibody drug conjugate and multi-specific antibody-based therapeutics. The company develops its pipeline products through Xpress CF platform, a biochemical protein synthesis system, for the treatme …
  • Cellmid Ltd (CDY):製薬・医療:M&Aディール及び事業提携情報
    Summary Cellmid Ltd (Cellmid), formerly Medical Therapies Ltd, is a life sciences company that develops and commercializes diagnostic and therapeutic products. The company holds comprehensive portfolio of intellectual property relating to the novel targets midkine and FGF5. It offers products such a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆